首页
400-620-6333
小分子和化合物库
选项
-
大黄素-d4CAS号: 132796-52-2分子式: C15H6D4O5 分子量: 274.26IUPAC Name: 1-deuterio-4,5,7-trihydroxy-2-(trideuteriomethyl)anthracene-9,10-dioneSMILES: CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)OInChIKey: RHMXXJGYXNZAPX-MZCSYVLQSA-NInChI: 1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3/i1D3,2D
-
Fmoc-Gly-OH-¹³C₂,¹⁵NCAS号: 285978-13-4分子式: (H15N-Fmoc)13CH213CO2H 分子量: 300.28IUPAC Name: 2-(9H-fluoren-9-ylmethoxycarbonyl(15N)amino)acetic acidSMILES: C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCC(=O)OInChIKey: NDKDFTQNXLHCGO-KBBTWOTBSA-NInChI: 1S/C17H15NO4/c19-16(20)9-18-17(21)22-10-15-13-7-3-1-5-11(13)12-6-2-4-8-14(12)15/h1-8,15H,9-10H2,(H,18,21)(H,19,20)/i9+1,16+1,18+1
-
L-精氨酸-¹⁵N₄盐酸盐CAS号: 204633-95-4分子式: C6H1415N4O2·HCl 分子量: 214.64IUPAC Name: (2S)-2-(15N)azanyl-5-[bis(15N)(azanyl)methylideneamino]pentanoic acid;hydrochlorideSMILES: C(CC(C(=O)O)N)CN=C(N)N.ClInChIKey: KWTQSFXGGICVPE-JYJSWXFRSA-NInChI: 1S/C6H14N4O2.ClH/c7-4(5(11)12)2-1-3-10-6(8)9;/h4H,1-3,7H2,(H,11,12)(H4,8,9,10);1H/t4-;/m0./s1/i7+1,8+1,9+1,10+1;
-
甘氨酸-1-¹³C,¹⁵NCAS号: 112898-03-0分子式: H215NCH213CO2H 分子量: 77.05IUPAC Name: 2-(15N)azanylacetic acidSMILES: C(C(=O)O)NInChIKey: DHMQDGOQFOQNFH-SUEIGJEOSA-NInChI: 1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)/i2+1,3+1
-
甘氨酸-¹³C₂,¹⁵NCAS号: 211057-02-2分子式: H215N13CH213CO2H 分子量: 78.05IUPAC Name: 2-(15N)azanylacetic acidSMILES: C(C(=O)O)NInChIKey: DHMQDGOQFOQNFH-VMIGTVKRSA-NInChI: 1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)/i1+1,2+1,3+1
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAF
CAS号: 2050232-20-5SMILES: [Belantamab mafodotin] -
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号: 1401812-88-1 -
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: SMCC-DM1
CAS号: 1008106-64-6 -
Lutikizumab (anti-IL1a&IL1b)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1791411-57-8 -
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: CL2A-SN-38
CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1167985-17-2 -
Sacituzumab govitecan (anti-TROP2)关联靶标: TACSTD2
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Mc-VC-PAB-SN38
CAS号: 1491917-83-9SMILES: [Sacituzumab govitecan]
